Allstate Investment Management’s Pfizer PFE Stock Holding History

Allstate Investment Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$11.7M	Buy	+228,769	New	+$11M	0.36%	41

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Allstate Investment Management's PFE Position: Q4 2022 in Review

Allstate Investment Management opened a new position in Pfizer (PFE) in Q4 2022: 228,769 shares worth $11.7M. The stake represents 0.36% of the portfolio and ranks #41 among its holdings.

3,268 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

Allstate Investment Management held 228,769 shares of Pfizer worth $11.7M as of Q4 2022.
Pfizer was a new Allstate Investment Management position in Q4 2022.
Pfizer made up 0.36% of Allstate Investment Management's portfolio in Q4 2022, its #41 holding.
3,268 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Allstate Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.